Clinical evaluation strategies for a live attenuated tetravalent dengue vaccine (2015)
Subjects: VACINAÇÃO, DENGUE (TERAPIA), VACINAS VIRAIS, INSTITUTOS DE PESQUISA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PRECIOSO, Alexander Roberto et al. Clinical evaluation strategies for a live attenuated tetravalent dengue vaccine. Vaccine, v. 33, n. 50, p. 7121-7125, 2015Tradução . . Disponível em: https://doi.org/10.1016/j.vaccine.2015.09.105. Acesso em: 13 set. 2024.APA
Precioso, A. R., Palacios, R., Thomé, B., Mondini, G., Braga, P., & Kalil, J. (2015). Clinical evaluation strategies for a live attenuated tetravalent dengue vaccine. Vaccine, 33( 50), 7121-7125. doi:10.1016/j.vaccine.2015.09.105NLM
Precioso AR, Palacios R, Thomé B, Mondini G, Braga P, Kalil J. Clinical evaluation strategies for a live attenuated tetravalent dengue vaccine [Internet]. Vaccine. 2015 ; 33( 50): 7121-7125.[citado 2024 set. 13 ] Available from: https://doi.org/10.1016/j.vaccine.2015.09.105Vancouver
Precioso AR, Palacios R, Thomé B, Mondini G, Braga P, Kalil J. Clinical evaluation strategies for a live attenuated tetravalent dengue vaccine [Internet]. Vaccine. 2015 ; 33( 50): 7121-7125.[citado 2024 set. 13 ] Available from: https://doi.org/10.1016/j.vaccine.2015.09.105
